SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19.
Authors: Sahanic S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Hilbe R; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Dünser C; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Tymoszuk P; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Löffler-Ragg J; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Rieder D; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Trajanoski Z; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Krogsdam A; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Demetz E; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Yurchenko M; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; The Central Norway Regional Health Authority, St. Olavs Hospital HF, Trondheim, Norway., Fischer C; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Schirmer M; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Theurl M; Department of Internal Medicine III, Medical University of Innsbruck, Innsbruck, Austria., Lener D; Department of Internal Medicine III, Medical University of Innsbruck, Innsbruck, Austria., Hirsch J; Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria., Holfeld J; Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria., Gollmann-Tepeköylü C; Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria., Zinner CP; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Tzankov A; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Zhang SY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA., Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Howard Hughes Medical Institute, New York, NY, 10065, USA., Posch W; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Austria., Wilflingseder D; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Austria., Weiss G; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria., Tancevski I; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Source: Heliyon [Heliyon] 2023 Nov 17; Vol. 9 (11), pp. e21893. Date of Electronic Publication: 2023 Nov 17 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-8440
DOI:10.1016/j.heliyon.2023.e21893